Baldock Jennifer 4

What Happened

• Jennifer Baldock, Chief Administrative & Development Officer of Surgery Partners (SGRY), sold 5,798 shares in an open-market/private sale on March 12, 2026. The weighted average sale price was $13.17 per share, for proceeds of $76,360. The sale was made to satisfy tax withholding obligations related to restricted stock that vested on March 4, 2026.

Key Details

• Transaction date: 2026-03-12; weighted average price reported: $13.17; total proceeds: $76,360. (Footnote: issuer can provide breakdown of shares sold at each price.)
• Reason: Shares sold to satisfy the reporting person’s tax withholding obligations in connection with restricted stock vesting (footnote F1).
• Filing date / Form 4 received: 2026-03-16 — filed within the normal 2-business-day window (not a late filing).
• Shares owned after the transaction: not disclosed in the provided Form 4 excerpt.
• Footnote F2: the price shown is a weighted average; full per-price details are available on request to the issuer, shareholders, or SEC staff.

Context

• This was a routine sale to cover tax withholding from a restricted stock vesting event (not a separate discretionary sale). Such tax-withholding sales are common and do not necessarily indicate a change in an insider’s view of the company.